JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

ISRG

483.28

+0.46%↑

BSX

105.3

+0.4%↑

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

ISRG

483.28

+0.46%↑

BSX

105.3

+0.4%↑

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

ISRG

483.28

+0.46%↑

BSX

105.3

+0.4%↑

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

ISRG

483.28

+0.46%↑

BSX

105.3

+0.4%↑

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

ISRG

483.28

+0.46%↑

BSX

105.3

+0.4%↑

Search

Thermo Fisher Scientific Inc

Closed

SectorHealthcare

462.78 -1.04

Overview

Share price change

24h

Current

Min

460.41

Max

463.45

Key metrics

By Trading Economics

Income

100M

1.6B

Sales

491M

11B

P/E

Sector Avg

28

40.048

EPS

5.15

Dividend yield

0.34

Profit margin

14.878

Employees

125,000

EBITDA

-1.8B

-74M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+17.46% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.34%

2.45%

Next Earnings

22 Oct 2025

Next Dividend date

15 Oct 2025

Next Ex Dividend date

15 Sept 2025

Market Stats

By TradingEconomics

Market Cap

30B

183B

Previous open

463.82

Previous close

462.78

News Sentiment

By Acuity

25%

75%

51 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

Thermo Fisher Scientific Inc Chart

Past performance is not a reliable indicator of future results.

Related News

23 Jul 2025, 10:33 UTC

Earnings

Thermo Fisher Scientific 2Q Profit, Revenue Rise

25 Jun 2025, 21:19 UTC

Acquisitions, Mergers, Takeovers

Solventum Removes Drinking-Water Unit From Thermo Fisher's Planned Filtration Buy

28 May 2025, 14:02 UTC

Acquisitions, Mergers, Takeovers

Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34 Billion

23 Apr 2025, 10:33 UTC

Earnings

Thermo Fisher 1Q Net, Revenue Up, Costs Stable

25 Feb 2025, 14:05 UTC

Acquisitions, Mergers, Takeovers

Thermo Fisher Scientific to Acquire Solventum's Filtration Unit, Confirming WSJ Report

23 Jul 2025, 10:00 UTC

Earnings

Thermo Fisher 2Q Organic Revenue Rose 2% >TMO

23 Jul 2025, 10:00 UTC

Earnings

Thermo Fisher 2Q Adj EPS $5.36 >TMO

23 Jul 2025, 10:00 UTC

Earnings

Thermo Fisher 2Q Net $1.62B >TMO

23 Jul 2025, 10:00 UTC

Earnings

Thermo Fisher 2Q EPS $4.28 >TMO

23 Jul 2025, 10:00 UTC

Earnings

Thermo Fisher 2Q Rev $10.85B >TMO

14 Jul 2025, 16:12 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

14 Jul 2025, 15:06 UTC

Acquisitions, Mergers, Takeovers

Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit -- Barrons.com

28 May 2025, 13:47 UTC

Acquisitions, Mergers, Takeovers

Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34B

23 Apr 2025, 10:01 UTC

Earnings

Thermo Fisher 1Q Adjusted Operating Margin 21.9% >TMO

23 Apr 2025, 10:00 UTC

Earnings

Thermo Fisher 1Q Organic Revenue Rose 1% >TMO

23 Apr 2025, 10:00 UTC

Earnings

Thermo Fisher 1Q EPS $3.98 >TMO

23 Apr 2025, 10:00 UTC

Earnings

Thermo Fisher 1Q Rev $10.36B >TMO

23 Apr 2025, 10:00 UTC

Earnings

Thermo Fisher 1Q Adj EPS $5.15 >TMO

23 Apr 2025, 10:00 UTC

Earnings

Thermo Fisher 1Q Net $1.51B >TMO

25 Feb 2025, 14:09 UTC

Acquisitions, Mergers, Takeovers

Thermo Fisher Strikes Deal for Solventum's Filtration Unit -- WSJ

25 Feb 2025, 13:41 UTC

Acquisitions, Mergers, Takeovers

Solventum: Transaction Is Expected to Be Completed by End of 2025 >SOLV

25 Feb 2025, 13:40 UTC

Acquisitions, Mergers, Takeovers

Solventum Expects Estimated $3.4 B in Net Proceeds >SOLV

25 Feb 2025, 13:40 UTC

Acquisitions, Mergers, Takeovers

Solventum: Deal Strengthens Balance Sheet With Proceeds to Be Used Primarily for Debt Paydown >SOLV

25 Feb 2025, 13:40 UTC

Acquisitions, Mergers, Takeovers

Solventum Expects Deal to Be Neutral to 2025 EPS >SOLV

25 Feb 2025, 13:40 UTC

Acquisitions, Mergers, Takeovers

Solventum: Deal Accelerates Business Transformation and Sharpens Focus on Strategic Areas for Growth

25 Feb 2025, 13:39 UTC

Acquisitions, Mergers, Takeovers

Solventum Announces Sale of Its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B

25 Feb 2025, 13:33 UTC

Acquisitions, Mergers, Takeovers

Thermo Fisher: Solventum Business Generated About $1 Billion Revenue in 2024 >TMO

25 Feb 2025, 13:32 UTC

Acquisitions, Mergers, Takeovers

Thermo Fisher to Buy Solventum Purification, Filtration Business for About $4.1 Billion Cash >TMO SOLV

25 Feb 2025, 13:32 UTC

Acquisitions, Mergers, Takeovers

Thermo Fisher Scientific To Acquire Solventum's Purification And Filtration Business >TMO

24 Feb 2025, 23:03 UTC

Acquisitions, Mergers, Takeovers

Thermo Fisher Scientific Nears Deal for Solventum's Purification and Filtration Business, Sources Say -- WSJ

Peer Comparison

Price change

Thermo Fisher Scientific Inc Forecast

Price Target

By TipRanks

17.46% upside

12 Months Forecast

Average 543.89 USD  17.46%

High 590 USD

Low 490 USD

Based on 18 Wall Street analysts offering 12 month price targets forThermo Fisher Scientific Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

18 ratings

14

Buy

4

Hold

0

Sell

Technical Score

By Trading Central

406.5 / 417.79Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Strong Bearish Evidence

Sentiment

By Acuity

51 / 374 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar